South & Central America Fish Vaccines Market
The South & Central America Fish Vaccines Market size was valued at US$ 21.25 Mn in 2022 and is projected to reach US$ 37.35 Mn by 2030, growing at a CAGR of 7.3% during 2022 - 2030.
Report Coverage
- Vaccine Type: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Recombinant Vector Vaccine
- Application: Bacterial Infection, Viral Infection, Parasitic
- Route of Administration: Injection Vaccine, Immersion Vaccine, Oral Vaccine
- Species: Salmon, Trout, Tilapia
US$ 21.25 Mn
Market size in 2022
US$ 37.35 Mn
Market Size by 2030
7.3%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Fish Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Fish Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Fish Vaccines Market Regional Analysis
6.2 South & Central America Fish Vaccines Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Fish Vaccines Market Forecast Analysis
7. South & Central America Fish Vaccines Market Analysis – by Vaccine Type
7.1 Inactivated Vaccines
- 7.1.1 Overview
- 7.1.2 Inactivated Vaccines: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Subunit Vaccines
- 7.3.1 Overview
- 7.3.2 Subunit Vaccines: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Recombinant Vector Vaccine
- 7.4.1 Overview
- 7.4.2 Recombinant Vector Vaccine: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. South & Central America Fish Vaccines Market Analysis – by Application
8.1 Bacterial Infection
- 8.1.1 Overview
- 8.1.2 Bacterial Infection: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Viral Infection
- 8.2.1 Overview
- 8.2.2 Viral Infection: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Parasitic
- 8.3.1 Overview
- 8.3.2 Parasitic: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. South & Central America Fish Vaccines Market Analysis – by Route of Administration
9.1 Injection Vaccine
- 9.1.1 Overview
- 9.1.2 Injection Vaccine: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Immersion Vaccine
- 9.2.1 Overview
- 9.2.2 Immersion Vaccine: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Oral Vaccine
- 9.3.1 Overview
- 9.3.2 Oral Vaccine: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. South & Central America Fish Vaccines Market Analysis – by Species
10.1 Salmon
- 10.1.1 Overview
- 10.1.2 Salmon: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Trout
- 10.2.1 Overview
- 10.2.2 Trout: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Tilapia
- 10.3.1 Overview
- 10.3.2 Tilapia: South & Central America Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. South & Central America Fish Vaccines Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America- 11.2.1 South & Central America Fish Vaccines Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 South & Central America Fish Vaccines Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 Brazil: South & Central America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 Brazil: South & Central America Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.1.2 Brazil: South & Central America Fish Vaccines Market Breakdown, by Application
- 11.2.1.1.3 Brazil: South & Central America Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.1.4 Brazil: South & Central America Fish Vaccines Market Breakdown, by Species
- 11.2.1.2 Argentina: South & Central America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Argentina: South & Central America Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.2.2 Argentina: South & Central America Fish Vaccines Market Breakdown, by Application
- 11.2.1.2.3 Argentina: South & Central America Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.2.4 Argentina: South & Central America Fish Vaccines Market Breakdown, by Species
- 11.2.1.3 Rest of South and Central America : South & Central America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South & Central America Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.3.2 Rest of South and Central America : South & Central America Fish Vaccines Market Breakdown, by Application
- 11.2.1.3.3 Rest of South and Central America : South & Central America Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.3.4 Rest of South and Central America : South & Central America Fish Vaccines Market Breakdown, by Species
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Elanco Animal Health Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Hipra SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Merck & Co Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Phibro Animal Health Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Vaxxinova International BV
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Zoetis Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full S Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
